Eiger BioPharmaceuticals, Inc. announced on April 1, 2024, Jeffrey S. Glenn notified the Company of his resignation as a member of the Company?s Board of Directors, to be effective April 1, 2024. Dr. Glenn?s resignation was not the result of any disagreement or dispute with the Company on any matter relating to the Company?s operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.272 USD | +1.00% | -15.52% | -66.26% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-66.26% | 3.37M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- EIGR Stock
- News Eiger BioPharmaceuticals, Inc.
- Eiger BioPharmaceuticals, Inc. Announces Resignation of Jeffrey S. Glenn as Member of the Board of Directors